Literature DB >> 15004076

Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Vincent B Young1, Thomas M Schmidt.   

Abstract

Alterations in the diversity of the gut microbiota are believed to underlie the development of antibiotic-associated diarrhea (AAD). A molecular phylogenetic analysis was performed to document temporal changes in the diversity of fecal bacteria of a patient who developed AAD. Antibiotic administration was associated with distinct changes in the diversity of the gut microbiota, including a marked decrease in the prevalence of butyrate-producing bacteria. Following the discontinuation of the antibiotic, resolution of diarrhea was accompanied by a reversal of these changes, providing the first direct evidence linking changes in the community structure of the gastrointestinal bacteria with the development of AAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004076      PMCID: PMC356823          DOI: 10.1128/JCM.42.3.1203-1206.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota.

Authors:  V J McCracken; R G Lorenz
Journal:  Cell Microbiol       Date:  2001-01       Impact factor: 3.715

2.  The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy.

Authors:  J R Cole; B Chai; T L Marsh; R J Farris; Q Wang; S A Kulam; S Chandra; D M McGarrell; T M Schmidt; G M Garrity; J M Tiedje
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods.

Authors:  Hidenori Hayashi; Mitsuo Sakamoto; Yoshimi Benno
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

Review 4.  The microbiology of butyrate formation in the human colon.

Authors:  Susan E Pryde; Sylvia H Duncan; Georgina L Hold; Colin S Stewart; Harry J Flint
Journal:  FEMS Microbiol Lett       Date:  2002-12-17       Impact factor: 2.742

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Human colonic biota studied by ribosomal DNA sequence analysis.

Authors:  K H Wilson; R B Blitchington
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

7.  Effect of a partially chemically defined diet on normal human fecal flora.

Authors:  H R Attebery; V L Sutter; S M Finegold
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

Review 8.  Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.

Authors:  C Dunne
Journal:  Inflamm Bowel Dis       Date:  2001-05       Impact factor: 5.325

Review 9.  Mechanisms and management of antibiotic-associated diarrhea.

Authors:  C Högenauer; H F Hammer; G J Krejs; E C Reisinger
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

10.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

View more
  118 in total

1.  Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations.

Authors:  Junhai Ou; James P DeLany; Ming Zhang; Sumit Sharma; Stephen J D O'Keefe
Journal:  Nutr Cancer       Date:  2011-12-02       Impact factor: 2.900

Review 2.  From structure to function: the ecology of host-associated microbial communities.

Authors:  Courtney J Robinson; Brendan J M Bohannan; Vincent B Young
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 3.  Xenobiotics: Interaction with the Intestinal Microflora.

Authors:  Kun Lu; Ridwan Mahbub; James G Fox
Journal:  ILAR J       Date:  2015

Review 4.  Experimental approaches for defining functional roles of microbes in the human gut.

Authors:  Gautam Dantas; Morten O A Sommer; Patrick H Degnan; Andrew L Goodman
Journal:  Annu Rev Microbiol       Date:  2013       Impact factor: 15.500

Review 5.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

Authors:  Robert A Britton; Vincent B Young
Journal:  Trends Microbiol       Date:  2012-05-15       Impact factor: 17.079

6.  Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia.

Authors:  Hana Hakim; Ronald Dallas; Joshua Wolf; Li Tang; Stacey Schultz-Cherry; Victoria Darling; Cydney Johnson; Erik A Karlsson; Ti-Cheng Chang; Sima Jeha; Ching-Hon Pui; Yilun Sun; Stanley Pounds; Randall T Hayden; Elaine Tuomanen; Jason W Rosch
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

7.  Introducing TreeClimber, a test to compare microbial community structures.

Authors:  Patrick D Schloss; Jo Handelsman
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

Review 8.  Emerging roles of the microbiome in cancer.

Authors:  Scott J Bultman
Journal:  Carcinogenesis       Date:  2013-12-03       Impact factor: 4.944

Review 9.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

10.  Probiotics L. acidophilus and B. clausii Modulate Gut Microbiota in Th1- and Th2-Biased Mice to Ameliorate Salmonella Typhimurium-Induced Diarrhea.

Authors:  Biswaranjan Pradhan; Dipanjan Guha; Aman Kumar Naik; Arka Banerjee; Subodh Tambat; Saurabh Chawla; Shantibhusan Senapati; Palok Aich
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.